Vitamin B12, also called cobalamin, is a water-soluble micronutrient required for critical cellular functions in human metabolism. Although often discussed as a dietary nutrient, it is functionally a cofactor for two essential enzymatic pathways: methionine synthase and methylmalonyl-CoA mutase. In the first pathway, B12 is needed for remethylation of homocysteine to methionine, which supports synthesis of S-adenosylmethionine, a key methyl donor for DNA synthesis, myelin maintenance, and neurotransmitter-related methylation reactions. In the second pathway, B12 participates in the conversion of methylmalonyl-CoA to succinyl-CoA, linking fatty acid metabolism to energy production. When B12 is deficient, impaired methylation and abnormal propionic acid metabolites contribute to ineffective hematopoiesis and neurologic dysfunction.
Absorption of vitamin B12 is a multistep, tightly regulated process involving gastric and intestinal physiology. Dietary B12 is typically bound to proteins and must be released in the stomach by gastric acid and pepsin, then bound to haptocorrin. In the duodenum and jejunum, pancreatic enzymes degrade haptocorrin, allowing B12 to bind intrinsic factor (IF) secreted by gastric parietal cells. The IF–B12 complex is absorbed in the terminal ileum via receptor-mediated endocytosis. This specificity explains why gastrointestinal disorders, surgical anatomy changes, and certain autoimmune conditions can cause deficiency even with adequate intake.
Common causes of vitamin B12 deficiency include pernicious anemia (autoimmune destruction of parietal cells and/or intrinsic factor), atrophic gastritis, inflammatory bowel disease affecting the terminal ileum, celiac disease, and history of gastrointestinal surgery such as gastrectomy or ileal resection. Reduced absorption may also occur with long-term use of acid-suppressing medications like proton pump inhibitors and H2 receptor blockers, as well as with metformin therapy, which can interfere with B12 absorption in susceptible individuals. Strict vegan or vegetarian diets without fortified foods and inadequate supplementation are another major risk factor. Alcohol misuse and certain medications that alter gut flora or nutrient handling may contribute indirectly.
Clinically, B12 deficiency classically presents with megaloblastic anemia and neurologic symptoms. Hematologic manifestations include fatigue, pallor, exertional dyspnea, and laboratory findings such as elevated mean corpuscular volume (MCV), macrocytosis, and hypersegmented neutrophils. Neurologic effects can include peripheral neuropathy (numbness, tingling), gait instability, cognitive changes, and in severe cases subacute combined degeneration of the spinal cord. Importantly, neurologic symptoms may occur even when anemia is not prominent, underscoring the need for timely diagnosis. Additional nonspecific features may include glossitis and weight changes.
Diagnosis relies on a structured evaluation. First-line laboratory testing often includes serum vitamin B12 and a complete blood count. If results are borderline or discordant with clinical suspicion, confirmatory markers can be used: serum methylmalonic acid (MMA) and homocysteine tend to rise in true B12 deficiency. Folate deficiency can produce overlapping hematologic findings, but it typically elevates homocysteine without significantly increasing MMA. Assessment of contributing causes may include testing for intrinsic factor antibodies when pernicious anemia is suspected, evaluation of gastrointestinal pathology, review of medication history, and consideration of dietary pattern.
Treatment depends on severity and etiology. In many cases, oral high-dose cyanocobalamin or other forms can be effective even in partial malabsorption, due to passive diffusion at supraphysiologic doses. However, if there is severe malabsorption, profound neurologic involvement, or inability to absorb enterally, parenteral therapy (intramuscular or subcutaneous B12 injections) is commonly recommended. Regimens vary by guideline and clinical context, but the therapeutic goal is restoration of stores and reversal of hematologic and neurologic abnormalities. Monitoring typically includes repeat blood counts and, when indicated, MMA or clinical symptom tracking.
From a prevention standpoint, dietary sources matter but must align with absorption capacity. Naturally occurring vitamin B12 is abundant in animal-derived foods. Common examples include fish (such as sardines, salmon, trout), shellfish (clams and mussels), meat (beef, liver), poultry, eggs, and dairy products. For individuals who do not consume animal products, fortified foods (fortified plant milks, fortified cereals) and supplementation are central strategies. The practical message for public health and clinical counseling is that adequate intake alone is not always sufficient when intrinsic factor is lacking or gastrointestinal absorption is impaired; therefore, medication review and early testing are often essential.
Because neurologic complications can become irreversible if treatment is delayed, clinicians should maintain a low threshold to evaluate risk groups, especially older adults, patients on long-term acid suppression, those with pernicious anemia or ileal disease, and individuals with dietary restriction. Evidence-based management combines nutritional assessment, targeted laboratory confirmation, and cause-directed therapy to mitigate hematologic and neurologic morbidity.
Source: @food_health_joy
Healthy Food: Vitamin B12 Sources🐟. #breaking
— @food_health_joy May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
